COVID-19 Update for Current Intragastric Balloon Patients ORBERA® OVERSTITCH™ X-TACK™ INVESTORS CONTACT US COMPANY Changing the way the global epidemic of obesity is managed. FOR PATIENTS FOR PROFESSIONALS ORBERA OverStitch X Tack HeliX REVOLUTIONIZING PATIENT CARE Leading Products in Minimally Invasive Therapies* * More than 277,000 people have safely used the ORBERA® weight loss balloon. LEARN MORE * Allows physicians to place full-thickness sutures through a flexible endoscope. LEARN MORE * Full-thickness suturing on single-channel endoscopes. LEARN MORE * Through-the-scope, suture-based system designed for difficult defect closures in the upper and lower gastrointestinal tract. LEARN MORE * Not all products are approved in all markets. Contact your local distributor for a list of Apollo Endosurgery, Inc. products approved for your country. Home Directions for Use Patent Notices Terms of Sale Website Terms of Use Privacy Policy MKT-01085-00R06 © 2021 Apollo Endosurgery, Inc.

COVID-19 Update for Current Intragastric Balloon Patients ORBERA® OVERSTITCH™ X-TACK™ INVESTORS CONTACT US COMPANY About Us We are dedicated to revolutionizing patient care through the development of endoscopic surgery. Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Home Directions for Use Patent Notices Terms of Sale Website Terms of Use Privacy Policy MKT-01085-00R06 © 2021 Apollo Endosurgery, Inc.